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Autophagy regulates hepatocyte identity and epithelial-
to-mesenchymal and mesenchymal-to-epithelial
transitions promoting Snail degradation
G Grassi1, G Di Caprio1,2, L Santangelo2, GM Fimia1,3, AM Cozzolino1,2, M Komatsu4, G Ippolito1, M Tripodi*,1,2,5 and T Alonzi*,1,5
Epithelial-to-mesenchymal transition (EMT) and the reverse process mesenchymal-to-epithelial transition (MET) are events
involved in development, wound healing and stem cell behaviour and contribute pathologically to cancer progression. The
identification of the molecular mechanisms underlying these phenotypic conversions in hepatocytes are fundamental to design
specific therapeutic strategies aimed at optimising liver repair. The role of autophagy in EMT/MET processes of hepatocytes was
investigated in liver-specific autophagy-deficient mice (Alb-Cre;ATG7fl/fl) and using the nontumorigenic immortalised hepatocytes
cell line MMH. Autophagy deficiency in vivo reduces epithelial markers' expression and increases the levels of mesenchymal
markers. These alterations are associated with an increased protein level of the EMT master regulator Snail, without transcriptional
induction. Interestingly, we found that autophagy degrades Snail in a p62/SQSTM1 (Sequestosome-1)-dependent manner.
Moreover, accordingly to a pro-epithelial function, we observed that autophagy stimulation strongly affects EMT progression,
whereas it is necessary for MET. Finally, we found that the EMT induced by TGFβ affects the autophagy flux, indicating that these
processes regulate each other. Overall, we found that autophagy regulates the phenotype plasticity of hepatocytes promoting their
epithelial identity through the inhibition of the mesenchymal programme.
Cell Death and Disease (2015) 6, e1880; doi:10.1038/cddis.2015.249; published online 10 September 2015
The epithelial-to-mesenchymal transition (EMT) is a complex
phenomenon by which epithelial-polarised cells lose their
polarity and cell–cell connections, acquiring mesenchymal
characteristics of motility and invasiveness. During EMT,
epithelial cells change their cytoskeleton and signalling
pathways, which reorganise cell shape and gene expression,
orchestrated by a restricted number of master transcription
factors, and among these Snail and Slug have a main role.1
The reverse process mesenchymal-to-epithelial transition
(MET), much less characterised at the molecular level,
restores the specific epithelial identity.2
EMT and MET are well-established biological events
occurring sequentially in development and organogenesis,
which are reactivated and regulated in wound healing, tissue
repair, fibrosis and cancer progression, in response to signals
from the proximal microenvironment. Therefore, the identifica-
tion of the molecular mechanisms underlying these pheno-
typic conversions in hepatocytes are fundamental to
understand the pathogenesis of liver diseases.
Autophagy is an intracellular pathway by which lysosomes
degrade and recycle proteins and cellular organelles. The
processes activated for lysosome delivery have defined three
types of autophagy: macroautophagy, microautophagy, and
chaperone-mediated autophagy. During macroautophagy
(herein after referred as autophagy), the materials to be
degraded are delivered to the lysosome through de novo
generation of a double-membrane vesicles, termed autopha-
gosomes, that sequester cytosolic targets and then fuse with
the lysosomes. Autophagic processes can be either constitu-
tive or activated in response to different stimuli.3
In the liver, autophagy has different functions important for
the organ homeostasis either in physiological conditions,
contributing to the maintenance of the energetic balance,
cellular quality control and the regulation of proteins turnover,
or in response to pathological stimuli, such as viral and
bacterial infections, DNA damage, toxic injuries or nutrient
deprivation. Autophagy dysregulation is involved in the
pathogenesis of different liver diseases, such as metabolic
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disorders, protein conformational diseases, viral infections
and hepatocarcinogenesis.4
In animal models, hepatocyte-specific autophagy deficiency
cause liver injury, severe hepatomegaly and tumorigenesis.
Autophagy-deficient hepatocytes accumulate protein aggre-
gates together with the sequestosome 1 (SQSTM1 or p62 and
hereinafter referred to as p62), an autophagy substrate and
cargo protein normally incorporated and degraded into the
autophagosomes in association with proteins that have to be
eliminated.5,6 In particular, the accumulation of p62 leads to
the activation of Keap1 (Kelch-like ECH-associated protein
1)–Nrf2 (nuclear factor (erythroid-derived 2)-like 2) pathway,
one of the major regulator of cytoprotective responses to
oxidative and electrophilic stress. p62 activates the transcrip-
tion factor Nrf2 by binding and inhibiting Keap1, an adaptor of
the ubiquitin ligase complex that targets Nrf2 for
degradation.7,8 Although observations from Nrf2- or p62-
deficient mice suggest that persistent activation of Nrf2,
caused by the impaired turnover of p62, accounts for most
of the pathogenic effects in the liver,9,10 little information on the
impact of autophagy in hepatocytes differentiation is available.
In this work, we investigated the functional relationship
between autophagy and hepatocyte differentiation with a
particular focus on EMT/MET dynamics. The role of autop-
hagy in the balance between epithelial and mesenchymal
states was investigated both in vivo, using liver-specific
ATG7-deficient mice (Alb-Cre;ATG7fl/fl),6 and in vitro, using
the immortalised nontumorigenic hepatocytic cell line MMH
(Met murine hepatocytes), which undergoes EMT upon
transforming growth factor beta1 (herein referred as TGFβ)
treatment and to MET upon TGFβ withdrawal.11–15 Here we
report that lack of autophagy leads to a decreased expression
of epithelial markers with the concomitant induction of the
mesenchymal programme. Autophagy promotes the degrada-
tion of Snail in hepatocytes through the action of p62. Moreover,
while the lack of autophagy leads to an increased EMTand an
impaired MET, autophagy induction prevents the transition of
hepatocytes from the epithelial to mesenchymal state.
Overall, our data unveil a new role played by autophagy in
hepatocyte pathophysiology, demonstrating that it contributes
to the maintenance of hepatocyte differentiation and epithelial
cell identity.
Results
Autophagy deficiency in hepatocytes correlates with
alteration of epithelial and mesenchymal markers' levels.
In order to investigate whether autophagy impairment
influences the hepatic gene expression, we measured the
levels of several epithelial and mesenchymal mRNAs in ATG7
liver-specific deficient mice (Alb-Cre;ATG7fl/fl) and their
autophagy-sufficient wild type littermates (ATG7fl/fl).6 As
shown in Figure 1a, the Alb-Cre;ATG7fl/fl mice display a
general reduced expression of epithelial-specific genes
(i.e., apolipoprotein(apo)A-I, apoC3, transthyretin, Albumin
and Hepatocyte nuclear factor (HNF) 4 alpha (HNF4α). On
the other hand, increased levels of several mesenchymal-
specific genes (i.e., Vimentin, matrix metalloproteinase
(MMP)-2, collagen type I alpha 1, tissue inhibitor of
metalloproteinase 1) were found in the autophagy-deficient
livers (Figure 1b). Western blotting analysis of the whole liver
extracts of these mice confirmed the downregulation of some
epithelial markers such as HNF1, HNF4α, Occludin and
Claudin (Figure 1c) and the upregulation of several
mesenchymal markers such as Vimentin, alpha smooth
muscle actin (αSMA), as well as the EMT-related transcrip-
tional factors Snail, Slug and Twist (Figure 1d). The levels of
p62 were also found increased, as expected by the lack of
autophagy (Figure 1d).6 These results suggest that in the
autophagy-deficient livers the fine regulation of the balance
between the mesenchymal and epithelial programmes is
altered.
To determine a possible molecular link between the
autophagy process and this phenotypic regulation, we used
a well-characterised cellular model, the differentiated, immor-
talised, nontumorigenic hepatocytic cell line MMH, capable of
undergoing a reversible EMT upon TGFβ stimulation.12–15
First, it was tested whether the lack of autophagy influences
the TGFβ-dependent EMT. To this aim, the expression of
Beclin1 (BECN1) and ATG7, two fundamental genes for
autophagy induction, was silenced by specific siRNAs in
hepatocytes. As shown in Figure 2, while the lack of either
BECN1 or ATG7 did not affect significantly the TGFβ-induced
morphological transition into fibroblastoid phenotype
(Figure 2a), it resulted in increased expression levels of
mesenchymal-specific genes such as MMP9, αSMA, Fibro-
nectin and Snail, when compared with cells transfected with
the negative control siRNA (Figure 2b). Although the protein
levels of E-cadherin, HNF1, HNF4α and Twist were not
significantly affected, Snail protein was significantly higher in
autophagy-deficient cells 24 h after TGFβ treatment
(Figure 2c), thus further suggesting that lack of autophagy
facilitates the transition from epithelial to mesenchymal state.
More interestingly, the silencing of either BECN1 or ATG7
induced increased levels of Snail protein also in untreated
cells (Figure 2d), without a significant upregulation of its gene
expression (Figure 2e). This result suggests that in hepato-
cytes Snail protein is constitutively degraded by autophagy.
Autophagy degrades Snail through p62. In order to
identify the molecular mechanism responsible for Snail
accumulation in the absence of autophagy, we first analysed
whether Snail interacts with the autophagy machinery.
First, we monitored the localisation of the microtubule-
associated protein 1A/1B-light chain 3 (LC3), a protein
necessary for autophagosome formation, and Snail. As
showed by confocal analysis of hepatocytes stably expressing
the green fluorescent protein-tagged LC3 (GFP-LC3), Snail
colocalised with autophagosomes (i.e., GFP-LC3 puncta), in
either untreated or TGFβ-treated (i.e., epithelial or mesench-
ymal phenotypes, respectively) cells (Figure 3a), thus
supporting the hypothesis that autophagy degrades the EMT
master regulator Snail in hepatocytes.
In the attempt to identify the cargo protein responsible for
Snail degradation, we focussed our attention on p62, which is
a regulator and substrate of autophagy and serves as a
receptor for selective autophagic clearance of protein aggre-
gates and organelles.16
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First, we analysed whether p62 interacts with Snail using
co-immunoprecipitation experiments. As shown in Figure 3b,
p62 co-immunoprecipitated with Snail specifically in TGFβ-
treated cells. However, the very low levels of Snail protein in
untreated cells could explain the lack of interaction with p62.
In fact, when the human Snail-HA (hematoagglutinin) and p62-
EGFP (enhanced GFP) were overexpressed in hepatocytes,
they co-immunoprecipitated in the absence of treatment,
therefore demonstrating that TGFβ is not necessary for Snail-
p62 interaction (Figure 3c).
Figure 1 Liver-specific autophagy-deficient mice express decreased levels of epithelial genes and increased mesenchymal markers levels. (a and b) mRNA levels of the
indicated genes were measured by quantitative real-time PCR (qPCR) in liver extracts of mice either autophagy-proficient (ATG7fl/fl; white column; n= 8) or autophagy-deficient
(Alb-Cre+;ATG7fl/fl; black column; n= 9). The values calculated byΔΔCT method are relative to L34 mRNA levels and expressed as fold of change with respect to control mice.
Data are expressed as mean± S.D. *Po0.01; #Po0.05; P-values were calculated by Mann–Whitney U-test. (c and d) Immunoblotting analysis for epithelial (c) and
mesenchymal (d) markers of whole liver extracts of mice either autophagy-proficient (ATG7fl/fl) or autophagy-deficient (Alb-Cre+;ATG7fl/fl). Tubulin and GAPDH were used for
protein loading control
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Figure 2 Lack of autophagy increases the mesenchymal markers expression. (a) Phase-contrast images of autophagy-deficient (siBECN1 or siATG7) or autophagy-
proficient (siCTR) cells either untreated (NT) or treated with TGFβ (2 ng/ml) for 24 h. (b) mRNAs levels of the indicated genes were measured by qPCR in siCTR, siBECN1 and
siATG7 cells either untreated (white columns) or treated with TGFβ (2 ng/ml) for 24 h (black columns). The values calculated byΔΔCT method are relative to L34 mRNA levels
and expressed as fold of change with respect to untreated siCTR cells. Data are shown as mean± S.D. of three independent experiments. *Po0.05; P-values were calculated by
Mann–Whitney U-test. (c and d) The protein levels of epithelial and mesenchymal markers were measured in autophagy-proficient (siCTR) or autophagy-deficient (siBECN1;
siATG7) cells either untreated or treated with TGFβ (2 ng/ml) for 24 h by western blotting. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used for protein loading
control. In panel (d), a higher amount of whole cell extracts proteins (30 versus 10 μg in panel (c)) were loaded to obtain a better Snail signal. (e) mRNA of Snail were measured
as in panel (b) in untreated siCTR, siBECN1 and siATG7 cells. *Po0.05 versus siCTR
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Figure 3 Autophagy degrades Snail in hepatocytes through the action of p62. (a) Colocalisation of LC3 with Snail was analysed by immunofluorescence staining for Snail
(red) in hepatocytes expressing GFP-LC3 (green). Cells, either untreated or stimulated with TGFβ, were treated with BafA1 (5 ng/ml) for 3 h, fixed, permeabilised, stained with an
anti-Snail antibody and analysed by confocal microscopy. In the magnified panels, arrows indicate the colocalisation of GFP-LC3 with Snail. (b) Immunoblotting analysis for Snail
and p62 following immunoprecipitation of either p62 or using an isotype-matched control mAb from lysates of parental cells either untreated or stimulated with TGFβ (2 ng/ml) for
3 h. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used for protein loading control. (c) Immunoblotting analysis for Snail and p62 following immunoprecipitation for
HA (Snail) in parental cells or in hepatocytes overexpressing Snail-HA either in the presence or absence of p62-EGFP (48 h posttransfection). GAPDH was used for protein
loading control. (d) Immunoblotting analysis of Snail and p62 following immunoprecipitation of either p62 or using an isotype-matched control mAb from lysates of autophagy-
deficient (shBECN1) or control (shCTR) cells either untreated or stimulated with TGFβ (2 ng/ml) for 3 h. In whole-cell extracts (bottom panels), BECN1 and GAPDH were used for
analysing the BECN1-silencing levels and as protein loading control, respectively. (e and f) Immunoblotting analysis for Snail and p62 of hepatocytes in which the expression of
p62 was either inhibited by two specific siRNAs (e) or increased by transfecting a p62-EGFP-expressing vector (f). GAPDH levels were used for protein loading control
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Next, we tested whether a functional autophagy is required
for p62-mediated Snail degradation using autophagy-deficient
hepatocyte cells in which BECN1 was stably silenced by a
short hairpin RNA (shRNA) approach (shBECN1). These cells
expressed higher levels of Snail protein, as evidenced by both
western blotting analysis (Figure 3d; lower panel) and
immunofluorescence (Supplementary Figure S1), thus con-
firming the results obtained with the siRNA approach
(Figure 2d). Co-immunoprecipitation experiments evidenced
a lower level of p62–Snail interaction in TGFβ-treated
shBECN1 cells when compared with the control-silenced cells
(shCTR) (Figure 3d). Although the immunoprecipitation assay
is not quantitative, this result suggests that an autophagy-
sufficient environment promotes the p62–Snail interaction. To
establish whether p62 either actively shuttles Snail to the
autophagosomes for degradation or mediates its accumula-
tion by inhibiting a negative regulator, similarly to what
reported for Twist or Nrf2,6,17,18 p62 was silenced by siRNAs.
As shown in Figure 3e, the lack of p62 resulted in increased
levels of Snail, thus strongly indicating that p62 acts as an
active cargo for the autophagy-mediated degradation of Snail.
This result was corroborated by the lack of increased Snail
protein level in p62-overexpressing cells (Figure 3f).
Overall, these data demonstrate that autophagy degrades
Snail through a p62-mediated mechanism in hepatocytes.
TGFβ-induced EMT causes autophagy impairment. In the
light of the evidence that Snail protein is a substrate of
autophagy, we decided to investigate whether autophagy is
modulated during EMT by analysing protein levels and
cellular localisation of LC3 and p62. First, we monitored the
electrophoretic mobility of LC3, which is known to change
upon autophagy induction, as the cytosolic form of LC3
(LC3-I) is covalently conjugated to phosphatidylethanolamine
generating the autophagosomal membrane-bound form LC3-
II. As shown in Figure 4a, TGFβ significantly increased the
endogenous LC3-I to LC3-II conversion starting 3 h after
treatment. Moreover, TGFβ induced the LC3 dots' formation,
which indicates autophagosome generation, as revealed by
cells stably expressing GFP-LC3 (Figure 4b, top panels).
Next, the levels of p62 were analysed. p62 serves as a
readout of autophagy degradation as it is known to bind to
ubiquitinated proteins for their delivery to autophagosomes
and degradation.19 In TGFβ-treated hepatocytes, we
observed an accumulation of p62 starting from 3 to 6 h
posttreatment (Figure 4a). Moreover, 24 h post-TGFβ treat-
ment p62 was mainly found with a dot distribution, which
suggests an autophagosomal localisation (Figure 4b, bottom
panels). These results indicate that the TGFβ inhibits the final
step of the autophagic flux.
To better elucidate whether the autophagy is inhibited
during EMT, we analysed the autophagy flux by measuring
LC3-II levels in cells treated with TGFβ, either in the absence
or presence of the lysosome-neutralising agent NH4Cl, which
prevents the degradation of autophagosomes. As shown in
Figures 4c and d, while NH4Cl causes an accumulation of
LC3-II in untreated cells, co-treatment with TFGβ does not
increase LC3-II levels, thus demonstrating that TGFβ inhibits
the degradation of LC3 rather than increasing the
autophagy flux.
Overall, these results suggest that the autophagy activity is
impaired during the TGFβ-induced EMT.
Induction of autophagy inhibits the TGFβ-mediated
EMT. As TGFβ impairs autophagy, we asked whether
stimulation of autophagy could influence EMT. As shown in
Figure 5, nutrient deprivation (starvation) significantly inhib-
ited the TGFβ-mediated EMT: (i) the fibroblastoid morphology
was prevented (Figure 5a); (ii) the repression of epithelial
genes was significantly affected; and (iii) the induction of
mesenchymal genes transcription was impaired (Figure 5c).
To test whether the TGFβ pathway is functional in starved
hepatocytes, we analysed the expression levels of Snail,
which is a TGFβ immediate early gene. Upon starvation,
TGFβ was able to stimulate Snail gene transcription
(Figure 5d), thus indicating that the TGFβ pathway was not
inhibited by nutrient deprivation. However, despite the mRNA
production, protein levels of Snail were significantly
decreased at each time point analysed (Figure 5e), therefore
confirming that autophagy affects Snail production by a
posttranslational mechanism.
It is worth to note that the TGFβ-induced EMTwas analysed
up to 12 h posttreatment, when the EMT programme is
induced while not yet complete. This was the last time point
studied, because prolonged nutrient deprivation and TGFβ
treatment caused massive cell death (Figure 5b).
To further assess the inhibitory role of autophagy in the
TGFβ-mediated EMT, we extended our observation to other
autophagy inducers, the mTOR inhibitor Torin120 and Treha-
lose, an autophagy inducer acting via a not yet identified
mTOR-independent pathway.21 In both Torin1- and Trehalose-
treated cells, EMT was significantly affected (Supplementary
Figures S2 and S3, respectively), and the levels of Snail
protein decreased (Figures 5f and g, respectively), despite its
mRNA levels was almost comparable to those of TGFβ-teated
cells (Supplementary Figures S2D and S3D, respectively).
Overall, these data indicated that autophagy counteracts
the EMT process triggered by TGFβ.
Lack of autophagy affects the hepatocytes MET. As the
inhibition of autophagy resulted in the upregulation of
the mesenchymal programme, we asked whether
autophagy contributes also to MET, the reacquisition
of the epithelial phenotype upon mesenchymal transition.
To address this issue, EMTwas first induced in either shCTR
or shBECN1 cells by 24 h of TGFβ treatment, and after TGFβ
withdrawal, MET was analysed for the following 48 h.
As shown in Figure 6, in autophagy-inhibited cells the
MET process was significantly delayed compared with
that of shCTR cells as assessed by: (i) the delayed
restoration of epithelial morphology and E-cadherin locali-
sation (Figure 6a), (ii) the decreased protein levels of
E-cadherin, HNF4α (Figure 6b), (iii) the increased levels of
Snail (Figure 6b), and (iv) the reduced expression of epithelial
genes (i.e., HNF4α, E-cadherin, ApoC3 and ApoA-I)
(Figure 6c).
These results demonstrated that autophagy is required for
the restoration of hepatocyte differentiation following an
environmental stress, such as the EMT-inducer TGFβ.
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Discussion
Autophagy is fundamental in hepatic homeostasis, for both
basic functions (i.e., energetic balance, removal of misfolded
proteins and damaged organelles) and the response to liver
insults (i.e., niche milieu modifications, pathogens infections,
DNA damage, toxic stimuli).4,22 The main contribution of this
work is the identification of a new role for autophagy in both
conditions: the maintenance of a stable differentiation state of
hepatocytes and in the EMT/MET processes.
Here we reported that autophagy actively degrades the
EMTmaster regulator Snail under basal condition, both in vivo
and in vitro, and supports the reacquisition of the epithelial
identity during MET. Notably, our data proved that autophagy
inhibition occurs during induction of EMT.
The constitutive degradation of Snail protein is important for
epithelial identity. In fact, it is becoming evident that the
balance between mesenchymal and epithelial master regula-
tors (i.e., Snail and HNF4α and HNF1α, respectively),
integrated by specific microRNAs regulation, is responsible
for stable maintenance of hepatocyte identity, aswell as for the
EMT/MET dynamics.2
Snail is a highly unstable protein, with a half-life of about
25min, and its degradation has been described to be triggered
by glycogen synthase kinase 3β phosphorylation and
mediated by the ubiquitin proteasome system (UPS).23 In
autophagy-competent cells, Snail is degraded by both
autophagy and proteasome (Supplementary Figure S4). The
raise in Snail levels that we observed in autophagy-deficient
hepatocytes was due to a decreased Snail degradation
Figure 4 TGFβ induces impaired autophagic flux in nontumorigenic hepatocytes. (a) Immunoblotting analysis of LC3, p62 and BECN1 in hepatocytes treated with TFGβ
(2 ng/ml) for the indicated hours. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) levels were used as loading control. (b) Fluorescence analysis of the localisation of LC3
or p62 in hepatocytes expressing either LC3-GFP or p62-GFP, respectively, following treatment with TGFβ (2 ng/ml) for 24 h. The blue is a ToPRO3 nuclear counterstaining.
(c) Immunoblotting analysis of LC3 in hepatocytes treated with TFGβ (2 ng/ml; 9 h) either in the presence or absence of the autophagy inhibitor NH4Cl (20 mM) for the last hour of
treatment. GAPDH was used for protein loading control. A representative experiment out of four is shown. (d) Quantification of the ratio of LC3-II to GAPDH band intensities
obtained by immunoblotting analysis as in panel (c), expressed as average ± S.D. (n= 4)
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mediated by p62, a multifunctional protein implicated in
several signal transduction pathways and in regulating
selective autophagy.16 Increased Snail levels were found in
p62-silenced cells (Figure 3e) and not in the p62-
overexpressing cells (Figure 3f), thus indicating that, in
hepatocytes, p62 does not increase Snail stabilisation through
the inhibition of its UPS-mediated degradation, similarly to
what found for the transcription factors Nrf27,8 or Twist.17,18
As, in addition to hepatocytes, we found increased Snail
levels in autophagy-deficient ambra1-null mouse embryonic
Figure 5 Autophagy stimulation inhibits the TGFβ-induced EMTand promotes Snail degradation in hepatocytes. (a) Phase-contrast images of cells treated with TGFβ (2 ng/ml)
in the absence (CTR) or presence (STV) of the starvation medium for 12 h. (b) Cell counts of hepatocytes cultivated either in normal medium alone (CTR) or with 2 ng/ml of TGFβ
(TGFβ) or cultivated in the starvation medium alone (STV) or with 2 ng/ml of TGFβ (STV+TGFβ) for 12 or 24 h, as indicated. (c) Levels of mRNAs of the indicated genes were
measured by qPCR in CTR or STV cells either untreated (white columns) or treated with TGFβ (2 ng/ml) (black columns) for 12 h. (d) Levels of Snail mRNA were measured by
qPCR in CTR (white columns) or STV (black columns) cells treated with TGFβ (2 ng/ml) for different time periods as indicated. The values calculated by ΔΔCT method are
relative to L34 mRNA levels and expressed as fold of change with respect to untreated cells. Data are expressed as mean± S.D. of three independent experiments. *Po0,05;
P-values were calculated by Mann–Whitney U-test. (e–g) Immunoblotting analysis for Snail in hepatocytes treated with TFGβ (2ng/ml) for different time periods as indicated. One
hour before TFGβ treatment, cells were left untreated or co-treated with starvation medium (STV) (e), Torin1 (1 μM) (f) or Trehalose (100 mM) (g). GAPDH (glyceraldehyde
3-phosphate dehydrogenase) was used as protein loading control
Autophagy supports hepatocyte epithelial programme
G Grassi et al
8
Cell Death and Disease
fibroblasts24 (Supplementary Figure S5) and that the activa-
tion of autophagy degrades Snail in human breast cancer and
in glioblastoma cells,25,26 we could speculate that autophagy
is a general mechanism controlling Snail levels, alternative
and synergistic with UPS. In addition to Snail protein
degradation, we found that autophagy could also affect the
Snail transcriptional regulation induced by TGFβ; in fact, in the
absence of autophagy (i.e., siATG7 and siBECN1) Snail
induction was increased (Figure 2b) while autophagy activa-
tion (i.e., starvation, mTOR inhibition or trehalose stimulation)
lead to a lower level of Snail mRNA (Figure 5d, Supplementary
Figures S2D and S3D), thus indicating that activators and/or
repressor of Snail gene are modulated by autophagy. This
point should be further investigated.
Although Snail has been described to be important for cell
cycle control and for mesenchymal identity in
hepatocytes,12,27,28 it has to be noted that in basal condition
autophagy inhibition per se is not sufficient to trigger a
'spontaneous' EMTor a cell cycle inhibition. However, as Snail
is sufficient to repress a broad repertoire of epithelial genes,
Figure 6 Lack of autophagy impairs the MET in hepatocytes. (a) Phase-contrast images and immunofluorescence analysis of the localisation of E-cadherin in hepatocytes.
Cells were treated with TGFβ (2ng/ml) for 24 h, extensively washed and after 0, 24 or 48 h of culture in the absence of TGFβ cells were fixed and stained for E-cadherin. (b)
Immunoblotting analysis of E-cadherin, HNF4α, Snail and BECN1 in shCTR or shBECN1 hepatocytes. Cells were lysed after 24 h of TGFβ (2 ng/ml) treatment or after 24 or 48 h
of further culture in the absence of TGFβ. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used as a loading control. (c) mRNA levels of the indicated genes were
measured by qPCR in shCTR or shBECN1 hepatocytes during EMT (24 h of 2 ng/ml of TGFβ; white columns) or during MET (further cultured in the absence of TGFβ for 24 (grey
columns) or 48 (black columns) hours). The values calculated by ΔΔCT method are relative to L34 mRNA levels. Data are expressed as mean±S.D. of three independent
experiments. *Po0.05; P-values were calculated by Mann–Whitney U-test
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including epithelial master regulator HNF4α, it could be
hypothesised that the impairment of its degradation renders
hepatocytes prone to EMT.
A second hint of interest of our data concerns the inhibitory
role of TGFβ on the autophagic flux. Although the molecular
mechanism was not investigated, we ruled out a transcrip-
tional downregulation of autophagy genes (i.e., ATG5, ATG7,
BECN1, ATG7 and p62) induced by TGFβ (data not shown).
The inhibitory effect of TGFβ on autophagy should not be a
surprise as it is known that it activates the autophagy inhibitor
mTOR through the PI3K–AKT pathway.29 However, it has
been reported that in hepatoma cells TGFβ activates
autophagy.30 Interestingly, this opposite effect of TGFβ on
autophagy in tumorigenic versus nontumorigenic hepatocytes
recalls the well-known 'TGFβ paradox in cancer progression',
where cell growth is inhibited in early stage and promoted at
late stage of tumors.31,32 As the 'cancer paradox' is also true
for autophagy, which has either antitumoral or pro-tumoral
functions,33 it is tempting to speculate that the TGFβ-mediated
dual activity on cancer progression could be exerted also
through a different regulation of autophagy. In agreement with
this hypothesis, while our results suggested that the lack of
autophagy increases the mesenchymal state of nontumori-
genic hepatocytes, the work of Peng et al.34 showed that in
hepatocellular carcinoma cells autophagy activates EMT,
promoting their invasion potential. This hypothesis is also
indirectly supported by results obtained on either normal
epithelial mammary gland cells in which autophagy activation
decreases EMT and cell migration35,36 or immortilised
podocytes in which autophagy inhibition leads to increased
mesenchymal and decreased epithelial markers.37
Our results also demonstrated that autophagy is required for
a successful MET. It could be speculated that autophagy is
necessary for the restoration of hepatocytes differentiation
and functions after an organ insult. Although we showed that
liver-specific Atg7 knockout mice display a decreased
epithelial-specific and increased mesenchymal-specific gene
expression, thus supporting this hypothesis, we cannot rule
out that this altered gene regulation could be due to a
secondary effect generated by the liver injury developed by
these mice. However, it is evident that the failure to properly
execute the autophagy programme renders hepatocytes
vulnerable to stressors and unable to provide the high
energetic demands, which are necessary to restore the
normal organ functionality. Besides the results here described
onAlb-Cre+;ATG7fl/fl mice andMMH cells, there are evidences
supporting this assumption. Autophagy deficiency in the liver
contributes to parenchymal damage (i) during a normal diet,
which is exacerbated after a methionine choline-deficient
diet,38 and (ii) in response to a tumor necrosis factor-
dependent liver injury.39 It has been also reported that
autophagy helps the hepatocyte polarisation during the bile
canaliculi formation, when cultured in a collagen sandwich
system.40 Moreover, in the light of our results, it is a very
interesting observation that the expression of Snail in
hepatocytes has a pro-fibrogenic role, in fact hepatocyte-
specific Snail deficiency (Alb-Cre+;Snailfl/fl mice) reduced liver
fibrosis induced by the carbon tetrachloride treatment.41 It is,
therefore, tempting to speculate that the autophagy-mediated
Snail degradation is helpful for contrasting fibrogenesis.
According to this hypothesis, it has been reported that
autophagy in hepatocytes exerts an antifibrogenic
effect.10,42–44 Interestingly, during liver fibrosis autophagy
exerts a functional paradox, it has an antifibrogenic effect in
hepatocytes or in macrophages while it has a pro-fibrogenic
role in hepatic stellate cells.45 These opposite effects on
fibrosis highlight the importance of understanding the role
played by autophagy in liver pathophysiology and to influence
the choice for a cell-specific pro-autophagy or antiautophagy
therapeutic approach.
Overall, our results showed that autophagy contributes to
the maintenance of a stable differentiation state of hepato-
cytes, counteracting the mesenchymal program either at the
basal level or during the phenotype transitions between
mesenchymal and epithelial state.
Materials and Methods
Mouse liver samples, cells and culture conditions. RNA and whole-
liver protein extracts of 4-, 9- and 11-month-old autophagy-deficient (Alb-Cre;ATG7fl/fl)
or autophagy-sufficient mice (ATG7fl/fl) were isolated as already described.5,6
The nontumorigenic differentiated epithelial MMH cell line was already described11
(see Supplementary Materials and Methods section for more details). Cells were
grown on collagen type I (BD Biosciences, San Jose, CA, USA) coated Petri dishes in
complete medium RPMI 1640 (Sigma-Aldrich, St Louis, MO, USA) supplemented
with 10% FBS (Gibco, Life Technologies, Grand Island, NY, USA), 50 ng/ml EGF
(PeproTech, Inc., Rocky Hill, NJ, USA), 30 ng/ml IGF-II (PeproTech), 10 mg/ml insulin
(Roche, Mannheim, Germany), 2 mM L-glutamine and 1% penicillin/streptomycin
solution (Sigma-Aldrich). For EMT induction, cells were treated with 2 ng/ml of TGFβ
(PeproTech). For MET induction, cells were initially transdifferentiated into
mesenchymal cells by 24 h of TGFβ (2 ng/ml) extensively washed and cultivated in
complete medium for 48 h.
For autophagy induction, cells were treated 1 h before TGFβ treatment with:
(i) Earle’s balanced salt solution (Sigma-Aldrich) for nutrient deprivation (Starvation);
(ii) Torin 1 (1 μM) (Tocris Bioscience Bristol, UK) or (iii) Trehalose (100 mM) (Sigma-
Aldrich).
For autophagy inhibition cells were either transfected with specific siRNAs
targeting BECN1 or ATG7 or infected with retroviruses expressing a shRNA specific
for BECN1 (see Supplementary Materials and Methods section for details).
To block lysosomal activity, cells were incubated in complete medium in the
presence of NH4Cl (20 mM; Sigma-Aldrich).
For autophagy markers' localisation, cells were infected with retroviruses
(pCLBCX) encoding for either GFP-LC3 or p62-GFP.46
For co-immunoprecipitation experiments, cells were transfected with plasmids
encoding human Snail tagged with HA (Snail-HA),47 a kind gift of Professor Amparo
Cano (Universidad Autónoma de Madrid (UAM), Madrid, Spain), alone or together
with plasmids encoding for human p62-EGFP,48 a kind gift of Professor Terje
Johansen, (University of Tromsø, Tromsø, Norway).
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